Patents by Inventor Robert Emmett McDevitt

Robert Emmett McDevitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
    Patent number: 7723329
    Abstract: The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
    Type: Grant
    Filed: August 14, 2006
    Date of Patent: May 25, 2010
    Assignee: Wyeth LLC
    Inventors: Hassan Mahmoud Elokdah, Alexander Alexei Greenfield, Kevin Liu, Robert Emmett McDevitt, Geraldine Ruth McFarlane, Cristina Grosanu, Jennifer Rebecca Lo, Yanfang Li, Albert Jean Robichaud, Ronald Charles Bernotas
  • AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS
    Publication number: 20090042964
    Abstract: The present invention provides a 2-amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compound of formula I The present invention also provides methods for the use thereof to inhibit ?-secretase (BACE) and treat ?-amyloid deposits and neurofibrillary tangles.
    Type: Application
    Filed: March 20, 2008
    Publication date: February 12, 2009
    Applicant: Wyeth
    Inventors: Michael Sotirios Malamas, Albert Jean Robichaud, Alexander Michael Porte, William R. Solvibile, Koi Michele Morris, Schuyler Adam Antane, Ji-In Kim, Robert Emmett McDevitt